enVVeno Medical Corporation

NASDAQ:NVNO

4.92 (USD) • At close April 15, 2024
Bedrijfsnaam enVVeno Medical Corporation
Symbool NVNO
Munteenheid USD
Prijs 4.92
Beurswaarde 65,519,640
Dividendpercentage 0%
52-weken bereik 2.51 - 6.97
Industrie Medical Devices
Sector Healthcare
CEO Mr. Robert A. Berman
Website https://www.envveno.com

An error occurred while fetching data.

Over enVVeno Medical Corporation

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency.

Vergelijkbare Aandelen

IN8bio, Inc. logo

IN8bio, Inc.

INAB

1.02 USD

Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc.

SPRO

1.53 USD

Neoleukin Therapeutics, Inc. logo

Neoleukin Therapeutics, Inc.

NLTX

3.49 USD

Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc.

COCP

1.408 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)